Original Research
Published on 19 Nov 2025
Multiomics profiling Identifies MCMBP as a prognostic biomarker and a potential immune-related target in pancreatic ductal adenocarcinoma via the JAK–STAT3 pathway
in Cancer Immunity and Immunotherapy
- 106 views